Publications (21) Publications de Alberto Cantalapiedra Diez

2023

  1. Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma

    Cancers, Vol. 15, Núm. 5

2021

  1. Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Identification of relapse-associated gene mutations by next-generation sequencing in low-risk acute myeloid leukaemia patients

    British Journal of Haematology, Vol. 189, Núm. 4, pp. 718-730

2018

  1. Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study

    Annals of Hematology, Vol. 97, Núm. 3, pp. 475-484

2016

  1. Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy

    British Journal of Haematology, Vol. 174, Núm. 6, pp. 859-867

2015

  1. Estudio de incidencia de las neoplasias hematopoyéticas en Castilla y León

    Medicina Clinica, Vol. 144, Núm. 11, pp. 491-500

2009

  1. Hematologic and cytogenetic response to lenalidomide in de novo acute myeloid leukemia with chromosome 5q deletion

    Leukemia Research

2008

  1. Tratamiento con anticoagulantes orales: dilemas y soluciones

    Anales de la Real Academia de Medicina y Cirugía de Valladolid, Núm. 45, pp. 71-84

2006

  1. Oral anticoagulant treatment: Risk factors involved in 500 intracranial hemorrhages

    Journal of Thrombosis and Thrombolysis, Vol. 22, Núm. 2, pp. 113-120

2004

  1. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction

    Circulation Research, Vol. 95, Núm. 7, pp. 742-748

  2. Trombosis venosa en pacientes con factor V Leiden

    Anales de la Real Academia de Medicina y Cirugía de Valladolid, Núm. 42, pp. 49-59

2003

  1. Emphysematous gastritis and severe aplastic anemia

    Hematology Journal, Vol. 4, Núm. 1, pp. 82-84

  2. Tratamiento de la coagulopatía en la sepsis severa

    Revista Clinica Espanola, Vol. 203, Núm. 5, pp. 240-241

2002

  1. Leucemia linfática crónica, fiebre y adenopatía inguinal

    Hematologia - Citocinas, Inmunoterapia y Terapia Celular, Vol. 5, Núm. 2, pp. 136-140

2000

  1. Is veno-occlusive disease a specific syndrome or the exacerbation of physiopathologic hemostatic changes in hematopoietic stem cell transplantation (HSCT)?

    Thrombosis Research, Vol. 99, Núm. 5, pp. 439-446

1999

  1. Aspectos practicos sobre el diagnostico y tratamiento de las mastocitosis del adulto

    Actas Dermo-Sifiliograficas, Vol. 90, Núm. 5, pp. 211-223

  2. Familial occurrence of primary antiphospholipid syndrome

    Thrombosis Research, Vol. 95, Núm. 2, pp. 127-129

  3. The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease

    British Journal of Haematology, Vol. 106, Núm. 2, pp. 400-405

1998

  1. Enfermedad de von Willebrand: Caracteristicas y respuesta a desmopresina. Estudio de 103 casos

    Medicina Clinica, Vol. 111, Núm. 16, pp. 601-603

  2. Mantle cell lymphoma with amyotrophic lateral sclerosis (motor neuron disease)

    Haematologica, Vol. 83, Núm. 4, pp. 382-383